A new targeted therapy against the KRAS G12D protein, a key driver of lung and pancreatic cancers, has shown early promise by shrinking tumors and delaying disease progression in advanced cases. …
A new study suggests that the organization of immune cells within melanoma tumors may help identify which patients will benefit from combination immunotherapy after standard anti-PD-1 treatment fails. …
A new class of engineered, supercharged T cells is stronger, longer-lasting, and more precise at killing prostate cancer cells by fine-tuning how they physically interact with tumor cells. …
New research reveals why some brain neurons resist the toxic buildup of tau protein—a hallmark of Alzheimer’s and related dementias—potentially aiding the development of new therapies. …
Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening. …
A new precision medicine approach that combines genetic and functional profiling helps predict how glioblastoma brain tumors will respond to therapy. …
Researchers found that a person’s psychosis risk may be influenced by both childhood attention problems and genetic factors. …
Researchers identified and synthesized a molecule that restores cognitive function in mice exhibiting symptoms of Alzheimer’s disease by effectively jumpstarting the brain’s memory circuitry. …
New research shows that the insomnia drug suvorexant prevents opioid addiction in mice while still providing effective pain relief. …
A cancer vaccine that targets KRAS mutations shows promising results in phase 1 trial with pancreatic and colorectal cancer patients. …
End of content
End of content
